CAS: 1564265-94-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (1R,3R,5R,2'S)-Saxagliptin REF: 4Z-S-3227CAS: 1564265-94-6 | - - - | To inquire | Wed 08 Jan 25 |
 | (2’S,2R,cis)-Saxagliptin REF: TR-S143485CAS: 1564265-94-6 | - - - | 15,186.00 € | Tue 18 Feb 25 |
 | (2S,2R,Cis)-saxagliptin REF: 3D-PMC26594CAS: 1564265-94-6 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: 4Z-S-3227
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
(2’S,2R,cis)-Saxagliptin
Controlled ProductCAS:1564265-94-6
Formula:
C18H25N3O2
Color and Shape:
Neat
Molecular weight:
315.41
Ref: TR-S143485
| 25mg | 15,186.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
(2S,2R,Cis)-saxagliptin
CAS:1564265-94-6
(2S,2R,Cis)-saxagliptin is a drug product that has been developed for the treatment of type II …
Formula:
C18H25N3O2
Purity:
Min. 95%
Molecular weight:
315.40 g/mol
Ref: 3D-PMC26594
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
